Ask Warren

Remed

302550 · KOSDAQ · ₩302550 · 리메드

₩2,290▲ ₩75 (3.39%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩25B₩26B₩19B₩21B₩20B
Cost of sales₩10B₩11B₩9.5B₩10B₩9.8B
Gross profit₩14B₩14B₩9B₩11B₩10B
Operating income₩726M₩1.1B−₩2.9B₩1.7B₩1.1B
Net income−₩35M₩7.4B₩319M₩4B₩752M
Net income to shareholders₩526M₩7.2B₩797M₩4B₩752M

Balance sheet

20252024202320222021
Total assets₩54B₩59B₩55B₩78B₩77B
Current assets₩28B₩29B₩22B₩42B₩49B
Cash and equivalents₩8.5B₩5.7B₩4.8B₩5.2B₩10B
Total liabilities₩14B₩19B₩24B₩48B₩51B
Current liabilities₩9.5B₩9B₩17B₩43B₩5.5B
Borrowings₩1.1B₩3.1B₩1.8B₩25B₩27B
Total equity₩39B₩40B₩31B₩30B₩26B
Shareholders' equity₩40B₩40B₩31B₩30B₩26B

Cash flow

20252024202320222021
Cash from operations₩2.4B₩1.2B₩3.5B₩5.2B−₩3.5B
Free cash flow₩2.4B₩1.2B₩3.5B₩5.2B−₩3.5B

Consolidated where available. Amounts in won.

Also known as: Remed / 리메드 / 302550 / KRX:302550

Source: KRX statistical information